Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

[1]  C. Heinlein,et al.  Androgen receptor in prostate cancer. , 2004, Endocrine reviews.

[2]  W. See,et al.  Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. , 2003, The Journal of urology.

[3]  H. Klocker,et al.  Androgen receptors in prostate cancer. , 2003, Endocrine-related cancer.

[4]  Z. İlçe,et al.  The sex hormone receptors in the bladder in childhood - I: preliminary report in male subjects. , 2002, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[5]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[6]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[7]  T. Tammela,et al.  Immunodetection of androgen receptor in human urinary bladder cancer , 1997, Histopathology.

[8]  C. M. Wilson,et al.  A and B forms of the androgen receptor are expressed in a variety of human tissues , 1996, Molecular and Cellular Endocrinology.

[9]  H. Klocker,et al.  Distant metastases from prostatic carcinoma express androgen receptor protein. , 1995, Cancer research.

[10]  H. Sasano,et al.  Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  T. H. van der Kwast,et al.  Androgen receptor expression in human tissues: an immunohistochemical study. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  P. Walsh,et al.  Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy , 1991, Cancer.

[13]  W. M. Linehan,et al.  Unexplained excess risk of bladder cancer in men. , 1990, Journal of the National Cancer Institute.

[14]  R. Noronha,et al.  Sex hormone receptors in localized and advanced transitional cell carcinoma of urinary tract in humans. , 1986, Urology.

[15]  L. Koss,et al.  Androgen receptors in bladder tumors. , 1985, Urology.

[16]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  Boorman Ga.  Animal model of human disease: carcinoma of the ureter and urinary bladder. , 1977, The American journal of pathology.

[18]  K. Yamada,et al.  Effect of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine , 1975, Urological Research.

[19]  Lofland Hb.  Animal model of human disease. , 1975, The American journal of pathology.

[20]  Z. Kırkalı,et al.  Androgen receptors in transitional cell carcinoma , 2006, International Urology and Nephrology.

[21]  K. Williamson,et al.  Oligoclonality in bladder cancer: the implication for molecular therapies. , 2004, The Journal of urology.

[22]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[23]  H. Akaza,et al.  Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats. , 1997, European urology.

[24]  J. A. van der Korput,et al.  The human androgen receptor: domain structure, genomic organization and regulation of expression. , 1989, Journal of steroid biochemistry.

[25]  K. L. Moore,et al.  The developing human , 1988 .